Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler
- Status
- COMPLETED
- Phase
- N/A
Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation
- Status
- COMPLETED
- Phase
- N/A
Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation
- Status
- TERMINATED
- Phase
- PHASE4
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice
- Status
- COMPLETED
- Phase
- N/A
Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects
- Status
- COMPLETED
- Phase
- PHASE1
HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales
- Status
- COMPLETED
- Phase
- PHASE3
Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Status
- COMPLETED
- Phase
- PHASE2
The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Tiotropium on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3